MEDDX | MEDGX | MEDDX / MEDGX | |
Total Expense Ratio | 1.81 | 0.81 | 223% |
Annual Report Gross Expense Ratio | 1.82 | 0.82 | 222% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 3.917 | 4.443 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.3B | 7.3B | 100% |
Annual Yield % from dividends | 5.07 | 6.05 | 84% |
Returns for 1 year | 6.74 | 7.82 | 86% |
Returns for 3 years | 28.66 | 32.53 | 88% |
Returns for 5 years | 5.73 | 11.13 | 51% |
Returns for 10 years | 27.32 | 40.69 | 67% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VCRAX | 14.43 | 0.15 | +1.05% |
NYLI CBRE Global Infrastructure Class A | |||
TWMTX | 132.95 | -0.04 | -0.03% |
Transamerica US Growth T | |||
FLPKX | 44.11 | -0.07 | -0.16% |
Fidelity Low-Priced Stock K | |||
AUUYX | 24.02 | -0.04 | -0.17% |
AB Select US Equity Advisor | |||
SBHEX | 10.62 | -0.04 | -0.38% |
Segall Bryant & Hamill Em Mkts Retl |